...and drug-resistant infections.Ribo applies for Shanghai STAR listingThe Shanghai Stock Exchange accepted an application from Suzhou Ribo Life Science Co. Ltd....
...its R&D team and construct a biochemical laboratory for internal compound testing. BC Staff ImmunoChina Eccogene Aegicare (Shenzhen) Technology Inhibikase Aivita Biomedical Suzhou Ribo Risen...

...Four months after closing a RMB203 million ($28.8 million) series C round, Suzhou Ribo Life Science Co. Ltd. has raised an...
...Ribo in China Partnership” ). Targets CASP2 - Caspase-2 GCGR - Glucagon receptor Hongjiang Li, Staff Writer Suzhou Ribo Life Science Co. Ltd. Glucagon...

...China for the anti-PD-1 mAb in 1H20. RNAi play Suzhou Ribo raises series C RNAi company Suzhou Ribo Life Science Co. Ltd....
...Inc. (NASDAQ:NVUS), which is developing specialty drugs for ear nose and throat disorders. Hongjiang Li, Staff Writer Suzhou Ribo Life Science Co. Ltd. Hummingbird...

...time” (see “China’s Dysfunctional Patent Flood” ). High profile Peking University professors founding companies include Suzhou Ribo Life Science Co. Ltd....
...Pharma Inc. Chinese Academy of Sciences EdiGene Inc. GlaxoSmithKline plc Hua Medicine Ltd. I-Mab Biopharma Innovative Cellular Therapeutics Co. Ltd. Peking University Pfizer Inc. Roche Suzhou Ribo Life Science Co. Ltd. Zai...

...Earlier this year, China Resources participated in a series B round for antisense company Suzhou Ribo Life Science Co. Ltd....

...Earlier this year, China Resources participated in a series B round for antisense company Suzhou Ribo Life Science Co. Ltd....

...Ionis said it granted Suzhou Ribo Life Science commercialization rights in China to two antisense drug candidates...
...Ionis Pharmaceuticals Inc. (NASDAQ:IONS), Carlsbad, Calif. Suzhou Ribo Life Science Co. Ltd. , Kushan, China Business: Cancer, Endocrine/Metabolic Shannon Lehnbeuter Ionis Pharmaceuticals Inc. Suzhou Ribo Life Science Co. Ltd....

...Ionis Pharmaceuticals Inc. (NASDAQ:IONS) said it granted Suzhou Ribo Life Science Co. Ltd. (Kushan, China) Chinese commercialization rights to two antisense...
...Beijing, China); ZHYT Investment Management; Legend Capital; GGV Capital; and Pan-Lin Asset Management. Becky Simon Ionis Pharmaceuticals Inc. Suzhou Ribo Life Science Co. Ltd....

...as 3 injections 2 months apart in about 352 patients. RiboQuark -- a JV between Suzhou Ribo...

...60 patients with unilateral acute primary angle-closure glaucoma. RiboQuark - a JV between RNAi companies Suzhou Ribo...